These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37999834)

  • 1. Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction.
    Tannous C; Ghali R; Karoui A; Habeichi NJ; Amin G; Booz GW; Mericskay M; Refaat M; Zouein FA
    Cardiovasc Drugs Ther; 2023 Nov; ():. PubMed ID: 37999834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.
    Diguet N; Trammell SAJ; Tannous C; Deloux R; Piquereau J; Mougenot N; Gouge A; Gressette M; Manoury B; Blanc J; Breton M; Decaux JF; Lavery GG; Baczkó I; Zoll J; Garnier A; Li Z; Brenner C; Mericskay M
    Circulation; 2018 May; 137(21):2256-2273. PubMed ID: 29217642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men.
    Dollerup OL; Chubanava S; Agerholm M; Søndergård SD; Altıntaş A; Møller AB; Høyer KF; Ringgaard S; Stødkilde-Jørgensen H; Lavery GG; Barrès R; Larsen S; Prats C; Jessen N; Treebak JT
    J Physiol; 2020 Feb; 598(4):731-754. PubMed ID: 31710095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction.
    Wang DD; Airhart SE; Zhou B; Shireman LM; Jiang S; Melendez Rodriguez C; Kirkpatrick JN; Shen DD; Tian R; O'Brien KD
    JACC Basic Transl Sci; 2022 Dec; 7(12):1183-1196. PubMed ID: 36644285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise.
    Stocks B; Ashcroft SP; Joanisse S; Dansereau LC; Koay YC; Elhassan YS; Lavery GG; Quek LE; O'Sullivan JF; Philp AM; Wallis GA; Philp A
    J Physiol; 2021 Mar; 599(5):1513-1531. PubMed ID: 33492681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
    Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
    Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model.
    Joshi U; Evans JE; Pearson A; Saltiel N; Cseresznye A; Darcey T; Ojo J; Keegan AP; Oberlin S; Mouzon B; Paris D; Klimas N; Sullivan K; Mullan M; Crawford F; Abdullah L
    Neurotoxicology; 2020 Jul; 79():84-94. PubMed ID: 32343995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside.
    Xiao Y; Wang Q; Zhang H; Nederlof R; Bakker D; Siadari BA; Wesselink MW; Preckel B; Weber NC; Hollmann MW; Schomakers BV; van Weeghel M; Zuurbier CJ
    Basic Res Cardiol; 2024 Jun; 119(3):403-418. PubMed ID: 38528175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.
    Ma S; Feng J; Lin X; Liu J; Tang Y; Nie S; Gong J; Wang L
    Oxid Med Cell Longev; 2021; 2021():5546867. PubMed ID: 34567409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice.
    Kim MB; Pham TX; vanLuling M; Kostour V; Kang H; Corvino O; Jang H; Odell W; Bae M; Park YK; Lee JY
    J Nutr Biochem; 2022 Sep; 107():109058. PubMed ID: 35643283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis.
    Hong G; Zheng D; Zhang L; Ni R; Wang G; Fan GC; Lu Z; Peng T
    Free Radic Biol Med; 2018 Aug; 123():125-137. PubMed ID: 29803807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HF-AF ENERGY Trial: Nicotinamide Riboside for the Treatment of Atrial Fibrillation in Heart Failure Patients.
    Pool L; Knops P; Manintveld OC; Brugts JJ; Theuns DAMJ; Brundel BJJM; de Groot NMS
    Cardiovasc Drugs Ther; 2023 Dec; 37(6):1243-1248. PubMed ID: 36227441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
    Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P
    Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
    Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
    Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUPPLEMENTATION WITH NICOTINAMIDE RIBOSIDE ATTENUATES T CELL EXHAUSTION AND IMPROVES SURVIVAL IN SEPSIS.
    Zhao GJ; Yang XY; Zhang C; Dong W; Dong FB; Zhang J; Chen XY; Yao RQ; Xiao Z; Chen LW; Yao YM; Lu ZQ
    Shock; 2023 Aug; 60(2):238-247. PubMed ID: 37314209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide ribose ameliorates myocardial ischemia/reperfusion injury by regulating autophagy and regulating oxidative stress.
    Yuan C; Yang H; Lan W; Yang J; Tang Y
    Exp Ther Med; 2024 May; 27(5):187. PubMed ID: 38533432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of NAD
    Metcalfe M; David BT; Langley BC; Hill CE
    Exp Neurol; 2023 Oct; 368():114479. PubMed ID: 37454712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases.
    Tannous C; Booz GW; Altara R; Muhieddine DH; Mericskay M; Refaat MM; Zouein FA
    Acta Physiol (Oxf); 2021 Mar; 231(3):e13551. PubMed ID: 32853469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice.
    Han X; Bao X; Lou Q; Xie X; Zhang M; Zhou S; Guo H; Jiang G; Shi Q
    PeerJ; 2019; 7():e7568. PubMed ID: 31523515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.